Alnylam Pharmaceuticals Joins Alliance to Enhance Genomic Research and Drive Precision Medicine Forward#United_States#San_Diego#Alnylam_Pharmaceuticals#Genomic_Discovery#RNAi_Therapeutics
Alnylam Pharmaceuticals Joins Alliance to Enhance Genomic Research and Drive Precision Medicine Forward
Alnylam Pharmaceuticals has joined the Alliance for Genomic Discovery to expand the genomic dataset that supports the development of precision medicine, enhancing drug discovery capabilities.
third-news.com
September 18, 2025 at 2:41 PM
Alnylam Pharmaceuticals Joins Alliance to Enhance Genomic Research and Drive Precision Medicine Forward#United_States#San_Diego#Alnylam_Pharmaceuticals#Genomic_Discovery#RNAi_Therapeutics
Alliance for Genomic Discovery Reaches Milestone with 250,000 Genomes to Propel Drug Discovery Forward#USA#Nashville#Illumina#Genomic_Discovery#Nashville_Biosciences
Alliance for Genomic Discovery Reaches Milestone with 250,000 Genomes to Propel Drug Discovery Forward
The Alliance for Genomic Discovery has successfully sequenced 250,000 whole genomes, laying the groundwork for innovative drug development and clinical research.
third-news.com
March 19, 2025 at 1:51 PM
Alliance for Genomic Discovery Reaches Milestone with 250,000 Genomes to Propel Drug Discovery Forward#USA#Nashville#Illumina#Genomic_Discovery#Nashville_Biosciences